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http://www.biomedcentral.com/1471-2091/14/1RESEARCH ARTICLE Open AccessThe COP1 E3-ligase interacts with FIP200, a key
regulator of mammalian autophagy
Saori Kobayashi, Noriko Yoneda-Kato, Nagisa Itahara, Akihiro Yoshida and Jun-ya Kato*Abstract
Background: The ubiquitin ligase COP1, COnstitutively Photomorphogenic 1, functions in many biological
responses in mammalian cells, but its downstream pathway remains unclear.
Results: Here, we identified FIP200, a key regulator of mammalian autophagy, as a novel COP1-interacting protein
by yeast two-hybrid screening. The interaction was confirmed by a GST-pulldown assay. Split-GFP analysis revealed
that interaction between COP1 and FIP200 predominantly occurred in the cytoplasm and was enhanced in cells
treated with UV irradiation. Different forms of FIP200 protein were expressed in cultured mammalian cells, and
ectopic expression of COP1 reduced one of such forms.
Conclusions: These data suggest that COP1 modulates FIP200-associated activities, which may contribute to a
variety of cellular functions that COP1 is involved in.
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COP1, COnstitutively Photomorphogenic 1, is the ubiqui-
tin ligase containing RING-finger, Coiled-coil and WD40
domains [1,2], and well conserved from plants to animals
[2]. In plants, COP1 was identified as one of the COP pro-
teins that act as a repressor of photomorphogenesis [1],
and functions downstream of the COP9 signalosome com-
plex [1-3] as a component of a multimeric E3 ubiquitin lig-
ase complex that includes Cullin 4 (CUL4), Damaged
DNA-Binding Protein 1 (DDB1), RING-Box 1 (RBX1), and
Suppressor of Phya (SPA) proteins [4]. In response to
multiple plant photoreceptors, the COP1-CUL4-DDB1-
RBX1-SPA complex controls many light-regulated tran-
scription factors [2,5].
In contrast to its specific role in plants, mammalian
COP1 is involved in many biological responses such as
tumorigenesis [6-9], DNA damage response [10,11], lipid
metabolism [12], and gluconeogenesis [13] by targeting
different substrates for degradation, which include p53
[6], c-Jun [8,14], Ets1/2 [9], TRB3 [12], and TORC2 [13].
Particularly, in a DNA-damage responsive pathway, COP1
functions downstream of ATM/ATR kinases by direct
phosphorylation [10,11], but the precise mechanism* Correspondence: jkata@bs.naist.jp
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COP1 action in various biological responses, components
and pathways downstream of COP1 are not fully under-
stood yet.
To better understand the COP1-signaling pathway, we
searched for novel COP1-interacting proteins by yeast
two-hybrid screening and identified FIP200 as one such
candidate. FIP200 (also known as RB1-inducible Coiled-
Coil 1, RB1CC1) was first reported as a regulator of the
retinoblastoma (RB) protein [15], identified as a tumor
suppressor in human breast cancer [16,17], and recently
rediscovered as a mammalian counterpart of Atg17 in
the yeast Atg1-Atg13-Atg17 complex [18]. The mamma-
lian ULK1(Atg1)-Atg13-FIP200(Atg17) complex func-
tions downstream of mTOR, and, together with the
Beclin 1-Vps34 kinase pathway and the Atg5-Atg12 and
LC3 conjugation systems, plays a key role in the induc-
tion of autophagy, an intracellular lysosomal degradation
system for cytoplasmic proteins and organelles [19-23].
In this study, we investigated the interaction between
COP1 and FIP200 by the yeast two-hybrid assay, the
GST-pulldown assay, and the Split-GFP assay. Proliferat-
ing mammalian cells expressed several different forms of
FIP200 protein, and one of them was downregulated by
the ectopic overexpression of COP1 protein, suggesting
that COP1 modulates FIP200-associated biologicalral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the complexity of the COP1-associated function.Results
Identification of FIP200 as an interactor with COP1
To explore the novel signaling pathway mediated by
COP1, we sought a candidate for interactors with COP1 by
yeast two-hybrid screening of the human K562 erythroleu-
kemia cDNA library. Out of 1.6 × 106 transformants, we
chose 13 potential clones that repeatedly exhibited positive
signals. These clones contained part of two independent
cDNAs, one for Jun D and one for FIP200 [24]/RB1-indu-
cible Coiled-Coil 1 [15] (RB1CC1). The presence of the
former cDNA was anticipated given that c-Jun is a sub-
strate of COP1 [14,25] and that JunD is highly homologous
to c-Jun, both of which belong to the same family of AP1
transcription factors. The latter component, FIP200, also
termed RB1CC1, was originally shown to control retino-
blastoma protein [15] and functions as a tumor suppressor
in human breast cancer [16]. FIP200 was recently rediscov-
ered as a component of the mammalian ULK1 (Atg1)-
Atg13-FIP200 (Atg17) complex and plays an important
role in the induction of autophagy [18]. Therefore, we
decided to investigate the COP1-FIP200 interaction andFigure 1 FIP200 interacts with COP1. (A) Y190 yeast cells were transfect
(ΔWD40 and ΔRING) of COP1 together with pACT vectors containing FIP20
medium and tested for β-galactosidase activity (top). Schematic structure o
proteins were immobilized on glutathione beads (bottom panel, separated
containing ectopically expressed HA-tagged wild-type and ΔWD40-mutant
using antibody against COP1 (upper panel).the role of COP1 in terms of UV response and induction
of autophagy.
A yeast two-hybrid analysis using deletion mutants of
COP1 (Figure 1A) indicated that the RING domain at
the N-terminus of COP1 [6], but not the WD40 domain,
is required for interaction with FIP200, showing a clear
difference from JunD, which interacted with the WD40
domain as is the case with most substrates for ubiquitin
ligases containing the WD40 motif [2]. In vitro binding
assays using GST-fused FIP200 protein (Figure 1B) and
cell lysate containing the ectopically expressed HA-
tagged COP1 (wild type and a mutant lacking the WD40
domain) showed that COP1 and FIP200 interacted
in vitro (Figure 1B).
Different forms of FIP200 protein were expressed in
cultured mammalian cells
To analyze the function of FIP200 in mammalian cells,
we raised a rabbit polyclonal antibody to FIP200 using a
polypeptide corresponding to the region isolated by the
yeast two-hybrid screening, which specifically reacted
with endogenous FIP200 as well as ectopically-expressed
FIP200 protein by Wester blotting (Figure 2A). In the
lysate isolated from proliferating mammalian cells, our
antibody recognized two forms of FIP200 (Figure 2B),ed with pAS2 vectors containing full-length and deletion mutants
0 and JunD. Transfectants were grown on a Trp- Leu- His- selection
f COP1 mutants (bottom). (B) GST and GST-FIP200 recombinant
by SDS-PAGE and stained with CBB) and mixed with cell lysate
form of COP1. Bound proteins were analyzed by Western blotting
Figure 2 Different forms of FIP200 protein were expressed in cultured mammalian cells. (A) HEK293T cells were mock-transfected (None)
and transfected with an expression vector containing HA-tagged FIP200. Cell lysates were analyzed by Western blotting using antibody against
FIP200. (B) NIH3T3, MEF, and 293T cells were lyzed in EBC and SDS sample buffers and analyzed by Western blotting using antibodies against
FIP200 and γ-tubulin. (C) NIH3T3 cells were treated with UV then incubated in complete medium, and lyzed in SDS sample buffer (input). Cell
lysates in SDS sample buffer were diluted with EBC buffer, and FIP200 protein was immunoprecipitated with antibody against FIP200, treated
with phosphatase, and visualized by Western blotting using antibody against FIP200. Cell lysates were also analyzed by Western blotting using
antibodies against COP1 and γ-tubulin. The ratio between upper and lower bands of FIP200 is also shown at the bottom of the FIP200 blot.
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from the cells (EBC buffer containing 0.5% NP40 versus
SDS sample buffer containing 1% SDS). Because we have
previously showed that COP1 is involved in cellular re-
sponse mediated by UV stimulation [11], we examined
whether UV might affect FIP200. Interestingly, UV
stimulation altered the ratio between these two forms
(Figure 2C); proliferating cells contained the slower mi-
grating form more, while UV treatment decreased the
expression of the slower migrating form and, instead,
increased that of the faster migrating form (the level of
COP1 declined after UV stimulation as previously
reported [11]).
FIP200 is known to be modified by phosphorylation
[26], which often affects mobility in SDS-PAGE. To test
this possibility, we extracted the protein from cells trea-
ted with UV and un-treated cells in an SDS sample buf-
fer, isolated FIP200 by immunoprecipitation, and treated
it with phosphatase in vitro. The result (Figure 2C)
showed that the difference in mobility was not due to
the level of phosphorylation although both forms were
phosphorylated. Currently, we do not know the exact
molecular identity of these two variants, which might be
generated by alternative splicing or other post-translational
modifications.
FIP200 interacts with COP1 in the cytoplasm of
proliferating cells in response to UV stimulation
We have so far not been successful in detecting the
COP1-FIP200 complex in cell lysate by immunoprecipi-
tation/immunoblotting. One possible explanation for
this is that our antibody does not recognize the complex.Another possibility is that the COP1-FIP200 complex
may not be efficiently eluted from the cells in a buffer
suitable for immunoprecipitation. In fact, we identified
different forms of FIP200 by Western blotting possibly
due to alternative splicing [16] and one of them was not
efficiently extracted in a buffer for immunoprecipitation
(Figure 2B).
To overcome these problems and to further investigate
the interaction between COP1 and FIP200 in vivo, we
performed a Split-GFP analysis [27], in which GFP (YFP)
was split into two domains, N-terminal (YN) and C-
terminal (YC), and fused to two molecules (COP1 and
FIP200 in this case), respectively (Figure 3A). If these
two molecules interact with each other in the cell, the
GFP (YFP) signal will be restored. In transfected cells,
COP1-YN, COP1-YC (both wild-type and mutant forms)
and FIP200-YN together with YC and YN did not gener-
ate any significant signals above the background level,
but we detected the GFP signal in the cells co-transfected
with both wild-type COP1-YC and FIP200-YN after UV
exposure (Figure 3B, C). The restored signal was predom-
inantly in the cytoplasm (mostly perinuclear) with some in
the nucleus too. We also detected interaction between
COP1-YN and COP1-YC as a control. In this case, the sig-
nal was both in the nucleus and in the cytoplasm
(Figure 3B). Quantification by flow cytometric analysis
showed that the COP1-COP1 interaction was constitutive,
whereas the COP1-FIP200 interaction was inducible in re-
sponse to UV treatment (Figure 3C). Importantly, inter-
action was diminished when we used a COP1 mutant
(SA), which contains a serine to alanine substitution at the
conserved ATM/ATR phosphorylation site at the 389th
Figure 3 Analysis of FIP200-COP1 interaction by Split GFP assay. (A) 293T cells were transfected with expression vectors encoding COP1
(wild type (WT) and phosphorylation-defect mutant (SA)) and FIP200 fused with N-terminal (YN) and C-terminal (YC) halves of YFP. Cell lysates
were analyzed by Western blotting using antibody against FIP200. (B, C) NIH3T3 cells were transfected with expression vectors encoding N-
terminal (YN) and C-terminal (YC) halves of YFP alone and fused with COP1 (wild type and SA mutant) and FIP200. Before and after treatment
with UV, GFP signals were observed using phase-contrast and fluorescence microscopy (B) and measured with a flow cytometer (C). Higher
magnification of photos of FIP200-COP1 and COP1-COP1 interactions are also shown (B, right panels). *; not significantly different (C).
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phosphorylation of COP1 is required for the efficient for-
mation of a complex between COP1 and FIP200. Taken
together, while COP1 stably forms a multimeric complex
in the cell, its binding to FIP200 in the cytoplasm is
enhanced by UV stimulation.Figure 4 Ectopic expression of COP1 reduced a form of FIP200 protei
HA-GFP and HA-GFP-fused COP1. After selection, cells were treated or non
using antibodies against COP1, FIP200, ULK1, Atg13, Atg101, and γ-tubulin.
HA-GFP and HA-GFP-fused COP1 (wild type and SA mutant). Cell lysates iso
normal rabbit serum (Control) and rabbit antibody to an HA-epitope (α-HA
against COP1. (C) Cells in panel B were treated with UV then incubated in
analyzed by Western blotting using antibodies against p53, FIP200, and γ-tEctopic expression of COP1 reduced the expression of a
certain form of FIP200 protein and exhibited
tumorigenisity in response to UV
To examine the effect of COP1 on FIP200, we ectopi-
cally expressed GFP-tagged COP1 in NIH3T3 (NIH/
GFP-COP1) cells. Figure 4A shows that the level ofn. (A) NIH3T3 cells were transfected with expression vectors encoding
-treated with MG132, harvested, and analyzed by Western blotting
(B) NIH3T3 cells were transfected with expression vectors encoding
lated from transfectants after selection were immunoprecipitated with
). Immune complex was analyzed by Western blotting using antibody
complete medium for 0, 8, and 16 hours. Cells were harvested, and
ubulin.
Figure 5 Effect of COP1 on UV-mediated tumorigenesis. NIH3T3
cells were transfected with expression vectors encoding HA-GFP and
HA-GFP-fused COP1 (wild type and SA mutant) and selected. After
exposure to UV (50 J/m2) and recovery culture, the cells (ca 106)
were subcutaneously injected into NOD-SCID mice. At 2.5 months
post-injection, mice were sacrificed and the weights of the tumors
were measured. Note that, except for the cells expressing the
ectopic wild-type COP1 with UV treatment, no trace of the cells
injected was detected. Therefore, the sizes and weights of the
tumors in those cases are actually 0. Cells (ca 106) recovered from
the tumors were injected into NOD-SCID mice, and the size of the
tumor was measured after 3 weeks (right column). The data are
averages for three independent experiments. Photos of the tumors
are also shown (upper).
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of the endogenous protein. Interestingly, the faster-
migrating form of FIP200 was downregulated in NIH/
GFP-COP1 cells compared to that of the control (NIH/
GFP) cells transfected with the control GFP-vector,
whereas the slower-migrating form remained the same.
Because it is known that FIP200 forms a complex with
ULK1, Atg13, and Atg101 to function downstream of
mTOR to induce autophagy [18,28], we investigated
their expression. Figure 4A shows that ectopic expres-
sion of COP1 affected differently; ULK1 was almost un-
affected, Atg13 was upregulated and Atg101 was slightly
downregulated. We did not detect any direct binding of
COP1 with ULK1, Atg13, and Atg101 (negative data not
shown), suggesting that COP1 affects these components
through interaction with FIP200. Interestingly, treatment
of cells with an inhibitor to proteasome, MG132, reversed
the effect of COP1 overexpression. When we investigated
autophagy in these cells, however, autophagy was fully
induced in response to amino acid starvation (negative
data not shown). COP1 may affect other activities asso-
ciated with FIP200.
Because interaction between COP1 and FIP200 was
enhanced by UV stimulation and SA mutation dimin-
ished the interaction, we ectopically expressed wild type
and SA mutant form of COP1 in NIH3T3 cells, and
examined the effect of UV on FIP200. Figure 4B, left
panel shows that both wild type and SA mutant COP1
were successfully overexpressed. Immunoprecipitation of
the HA-tagged exogenous COP1 protein with the anti-
body to the HA epitope brought down the endogenous
COP1 protein (Figure 4B, right panel), indicating that
COP1 formed a dimer or a larger multimeric complex,
which was expected from the split-GFP analysis (see
above, Figure 3). The SA mutant retained the ability to
interact with the endogenous COP1. Upon stimulation
with UV (Figure 4C), the slower migrating form of
FIP200 decreased and the faster migrating form increased
in control cells. Overexpression of wild type COP1
reduced the level of faster migrating form at time 0 and
blocked its induction by UV stimulation, whereas overex-
pression of SA mutant did not affect the band shift of
FIP200 upon UV stimulation.
FIP200 was identified as a tumor suppressor [16,17]. If
COP1 negatively regulates FIP200, one might expect that
COP1 act as an oncogene. In addition, COP1 responds
to UV stimulation and becomes a substrate of ATM/
ATR kinases [10,11]. We, therefore, tested whether the
overexpression of COP1 facilitates cellular transform-
ation in response to UV irradiation. We treated NIH3T3
mouse fibroblasts expressing COP1 with UV, let them
recover for passaging, and subcutaneously injected them
into NOD-SCID mice (Figure 5). Ectopic expression of
the COP1 protein itself was not tumorigenic because notrace of cells was detected 2 months after injection.
However, after treatment with UV and successive pas-
sages in a recovery culture, cells ectopically expressing
COP1 formed a tumor of significant size in mice. Im-
portantly, cells transfected with SA mutant of COP1,
which did not interact with FIP200 (Figure 3B, C), failed
to form tumors even after UV stimulation, suggesting
that COP1 requires interaction with FIP200 to exhibit
its oncogenic properties. We currently do not know the
physiological significance of the impact of COP1 overex-
pression on autophagy. However, considering the differ-
ential effect on the expression of the components of the
FIP200 complex and the FIP200 subtypes and that
tumorigenic function of COP1 requires interaction with
FIP200, it is feasible to say that COP1 may regulate bio-
logical activities associated with FIP200 in a certain
occasion.
Discussion
As distinct from its plant counterpart [1], mammalian
COP1 is involved in many biological occasions [2].
Multi-functionality of COP1 partly stems from its variety
of substrates and various adaptor or accessory proteins
to interact with. Although several proteins have been
identified as the target of COP1 [6,8,9,12-14], it is rea-
sonable to speculate that more substrates and down-
stream pathways are yet to be found. Our findings imply
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pathway mediated by COP1, which may partly explain the
multifunction of COP1 because autophagy is reported to
be involved in many biological occasions [20,21].
By yeast-two hybrid screening, we identified C-terminal
polypeptide of FIP200 as the interactor of COP1, and raised
antibody against this portion of the protein. Using this anti-
body, we detected at least two different forms of FIP200 in
proliferating mammalian cells, both of which should, there-
fore, share the epitope in the C-terminus of FIP200. Cur-
rently, we do not know the identity of these two forms of
FIP200 recognized by our antibody because phosphoryl-
ation (Figure 2) and ubiquitination (anti-ubiquitin antibody
failed to recognize either form. negative data not shown) do
not seem to account for the mobility difference of these
two forms. It is feasible to suspect that alternative splicing
generated these two forms, but the extensive RT-PCR ana-
lysis using a series of primers designed within different
exons failed to identify the alternative transcripts (negative
data not shown). Therefore we do not exclude the possibil-
ity that the faster-migrating form is the product of other
post-translational modifications. Whatever the mechanism,
it is important to emphasize that these two forms were
extracted in different conditions and that only the faster-
migrating form was downregulated by the ectopic expres-
sion of COP1, suggesting that they locate in different
compartments within the cell and that one of the two is the
possible target of COP1.
We do not yet know whether FIP200 is a substrate for the
COP1 ligase. FIP200 bound to the RING domain, but not
the WD40 domain, of COP1, which makes a clear difference
from other substrates such as JunD. We, so far, did not see
the ubiquitinated FIP200 protein in COP1-overexpressing
cells. However, we did observe the downregulation of faster-
migrating form of FIP200 in COP1-overexpressing cells in
an MG132-sensitive manner, suggesting that COP1 some-
how induced proteasome-mediated degradation of FIP200.
At present, we do not exclude the possibility that COP1
altered the level of FIP200 expression through mechanisms
other than direct ubiquitination. COP1 might affect
alternative-splicing to affect the expression of faster-
migrating form, which step is sensitive to the action of
proteasome.
Cells with ectopic overexpression of COP1 still under-
went autophagy in response to amino acid starvation
even though the faster-migrating form of FIP200 was ef-
ficiently downregulated, and the expression of Atg13
and Atg101 was modulated (although slightly). It could
be that the remaining components of the FIP200 com-
plex were sufficient to the initiate autophagic program
or alternative form of FIP200 may respond to different
inducers of autophagy such as UV. To answer this ques-
tion, molecular identification of two forms of FIP200 is
the urgent matter. Knowing the difference between thetwo, we could compare the composition of the different
complexes and examine the role of each form in re-
sponse to various stimuli, and the potential functions
associated with FIP200 in the cell cycle control [15], p53
regulation [17] and DNA damage repair [29] as well as
autophagy [18].
We have tried to establish the in vitro ubiquitination
assay for COP1 and FIP200 using recombinant proteins
without success (negative data not shown). This could
be due to the lack of the COP1-accessory proteins or, al-
ternatively, COP1 may favor the FIP200-containing com-
plex rather than a single polypeptide. In addition to the
identity of FIP200 variants, an adaptor protein of COP1
specific to FIP200 will be required for establishment of
the in vitro reconstitution system, which will give us
many clues to biochemically understand the nature of
COP1-associated activities in mammals.
Methods
Yeast two-hybrid screening
The entire coding sequence (full) and deletion mutants
(ΔWD40 and ΔRING,) of mouse COP1 were fused in-
frame to the GAL4 DNA-binding domain of the pAS2
vector [30]. The resulting ‘bait’ plasmid (pAS2-COP1)
was used to screen pACT- human K562 erythroleukemia
libraries (library size: 3 × 106, Clontech) by the yeast
two-hybrid method in Y190 yeast cells [11,30,31].
In vitro binding assay
A cDNA fragment containing the C-terminal domain of
FIP200 (amino acid residues 1357–1594) was inserted
into the pGEX vector (Pharmacia) in-frame with Gluta-
thione S-transferase (GST). Expression and purification
of GST-fused proteins and the binding conditions were
as described [11,32].
Cell culture, transfection, retroviral infection, and
treatment with UV
NIH3T3 (Arf-null, p53-wild-type) mouse fibroblasts (pro-
vided by Drs C. J. Sherr and M. F. Roussel), mouse embry-
onic fibroblasts (MEFs), and 293T human embryonic
kidney (HEK) cells were cultured, transfected via the cal-
cium phosphate-DNA precipitation method [33], and
infected with retroviral vectors as described [11,32,34].
For treatment with UV, cells were washed with PBS twice,
exposed to UV light in a UV Crosslinker (UVP, Upland,
CA) (25 or 50 J/m2), and incubated in a serum-containing
complete medium. In some cases, cells were treated with
5 μM MG132 (Biomol, Plymouth Meeting, PA) before
harvest.
Plasmid construction
The GFP-fused protein expression vector (pMSCV-
puro-GFP), into which COP1 cDNAs were subcloned,
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ΔRING and SA) [6,10,14,35] were generated by PCR.Protein analyses
Cell lysis, immunoprecipitation, sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE), and im-
munoblotting were performed as described [11,34]. Two
types of lysis buffer used in this study were EBC buffer
(50 mM Tris–HCl pH8.0, 120 mM NaCl, 1 mM EDTA,
and 0.5% NP40) containing 2000 KIU/ml of aprotinin,
1mM PMSF, 0.1 mM NaF, 0.1 mM Na3VO4, and 10 mM
β-glycerophosphate, and SDS-sample buffer (40 mM
Tris–HCl, pH 6.8, 0.1 M DTT, 1% SDS, 10% glycerol, and
0.05% Bromophenol Blue). In some cases, immunopreci-
pitated proteins were treated with phosphatase before im-
munoblotting [36]. A rabbit polyclonal antibody to an
HA-epitope (HA.11) was obtained from Santa Cruz. A
mouse monoclonal antibody to an HA-epitope (clone
12CA5) was purchased from Boehringer Mannheim.
Rabbit polyclonal antibodies to ULK1 (A7481) and Atg13
(SAB4200100) were from Sigma. Rabbit polyclonal anti-
bodies to LC3 (PM036) and p62 (PM045) were acquired
from Medical & Biological Laboratories (MBL). Rabbit
polyclonal antibodies to FIP200, p53, and COP1 were
generated using bacterially produced polypeptides in
our laboratory. A rabbit polyclonal antibody to Atg101
was provided by Dr. Noboru Mizushima.Split GFP assay
GFP (YFP) was split into two domains, N-terminal (YN:
amino acids 1–154) and C-terminal (YC: amino acids
155–238). Each domain was fused to two molecules
(full-length COP1 and FIP200 in this case), and trans-
fected into cells as described above. GFP signals were
observed using phase-contrast or fluorescence micros-
copy and measured with a flow cytometer. A human
cDNA clone containing entire coding sequence of
FIP200 was obtained from Kazasa DNA Research Insti-
tute (clone niumber: KIAA0203).Tumorigenicity assay
Cells (ca 106) were subcutaneously injected into NOD-
SCID mice. After 3 weeks or 2.5 months, mice were
sacrificed and the size of the tumor was measured.Conclusion
In this study, we found the interaction between FIP200
and COP1. Ectopic expression of COP1 reduced one of
the different forms of FIP200, suggesting that COP1
modulates FIP200-associated activities, which may con-
tribute to a variety of cellular functions that COP1 is
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